[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Arvinas, Inc Graphic](https://lunarcrush.com/gi/w:26/t:$arvn.png) Arvinas, Inc (ARVN)

Arvinas, Inc. (ARVN) and Pfizer to present new Vepdegestrant data at ESMO 2025, but the stock faces mixed sentiment due to analyst downgrades and market volatility.

### About Arvinas, Inc
Arvinas, Inc. (ARVN) is a biotechnology company focused on developing protein degraders for various diseases, particularly in oncology.  
Arvinas, Inc uses the ticker $ARVN for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$arvn/insights)
- Arvinas, Inc (ARVN) trading volume is up XXXXXX% from the previous month.
- Arvinas, Inc (ARVN) social dominance is up XXXXX% from the previous week.
- Arvinas, Inc (ARVN) galaxy score™ is up XXXXX% from the previous week.
- Arvinas, Inc (ARVN) sentiment is up XX% from the previous week.
- Arvinas, Inc (ARVN) posts created is up XXXXXX% from the previous week.

### Price: $XXXX [#](/topic/$arvn/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/close.tsv)  
The current price of $XXXX appears to be influenced by a mix of positive and negative factors. While the company's revenue growth and upcoming catalysts offer support, analyst downgrades and recent price drops suggest caution. The XXXXX% increase over the last XX days indicates some positive momentum, but the negative 7-day performance and 1-year low suggest potential for further volatility.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXXX% | XXXX%  |

**1-Year High**: $XX on 2024-11-11  
**1-Year Low**: $XXXX on 2025-05-14  
  
  
### AltRank: XXX [#](/topic/$arvn/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/alt_rank.tsv)  
Arvinas, Inc (ARVN) is currently AltRank #159 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX -XXX  
**6 Months**: XXX +79  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-09-04  
**1-Year Low**: XX on 2025-01-18  
  
  
### Galaxy Score: XXXXX [#](/topic/$arvn/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +33  
**1 Month**: XX -X  
**6 Months**: XX +4  
**1 Year**: XX +24  
**1-Year High**: XX on 2025-07-21  
**1-Year Low**: XX on 2024-11-26  
  
  
### Engagements: XXXXX [#](/topic/$arvn/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX +121%  
**1-Year High**: XXXXXXX on 2025-02-11  
**1-Year Low**: XXX on 2025-10-11  

| Social Network | X     | Reddit | YouTube |
| -------------- | -     | ------ | ------- |
| Engagements    | XXXXX | X      | X       |
  

  
  
### Mentions: XX [#](/topic/$arvn/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +7.30%  
**1 Year**: XXXXX +183%  
**1-Year High**: XXX on 2025-06-29  
**1-Year Low**: XX on 2025-10-12  

| Social Network | X  | Reddit | YouTube |
| -------------- | -  | ------ | ------- |
| Mentions       | XX | X      | X       |
  

  
  
### Creators: XX [#](/topic/$arvn/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Arvinas, Inc (ARVN) in the last XX hours which is up XXX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXXXX +92%  
**1 Year**: XXXXX +174%  
**1-Year High**: XXX on 2025-06-29  
**1-Year Low**: X on 2025-10-12  

The most influential creators that mention Arvinas, Inc in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@ByMadeleineA](/creator/twitter/ByMadeleineA)       | X    | XXXXX     | X     | XXXXX       |
| [@Banana_Oncology](/creator/twitter/Banana_Oncology) | X    | XXXXX     | X     | XXX         |
| [@financebully](/creator/twitter/financebully)       | X    | XXX       | X     | XXX         |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | X    | XXX       | X     | XX          |
| [@doepke_michel](/creator/twitter/doepke_michel)     | X    | XXXXX     | X     | XX          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XX          |
| [@Insider_WTrade](/creator/twitter/Insider_WTrade)   | X    | XXXXX     | X     | XX          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | X     | XX          |
| [@aultfern](/creator/twitter/aultfern)               | X    | XXX       | X     | XX          |
| [@Biobeats99](/creator/twitter/Biobeats99)           | XX   | XXX       | X     | XX          |

[View More](/list/creators/$arvn/100)
  
  
### Sentiment: XX% [#](/topic/$arvn/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +25%  
**1 Month**: XX% -X%  
**6 Months**: XX% +8%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-11-08  
**1-Year Low**: XX% on 2025-10-03  

**Most Supportive Themes**
- **Positive Analyst Ratings and Partnerships:** (25%) Mentions of partnerships and positive analyst ratings, such as the one from Bank of America, are seen as supportive.
- **Upcoming Catalysts and Data Releases:** (20%) The anticipation surrounding the ASCO presentation and regulatory filings for ARV-471 is a supportive theme.
  
**Most Critical Themes**
- **Analyst Downgrades:** (15%)  Downgrades from Truist and BMO are viewed as critical.
- **Market Volatility:** (10%)  The stock's price fluctuations and negative 7-day performance are critical.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |
| Reddit  | X        | X%  | X       | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$arvn/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXX% +0.0099%  
**1 Month**: XXXXXX% +0.0011%  
**6 Months**: XXXXXX% -XXXXX%  
**1 Year**: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**1-Year High**: XXXXX% on 2025-03-14  
**1-Year Low**: XXXXXX% on 2025-10-12  
  
  
### Market Dominance: XXXXXXXXXXXXXXXXXXXXX% [#](/topic/$arvn/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXXXXXXXXXXXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXXXX% on 2024-11-22  
**1-Year Low**: XXXXXXX% on 2025-08-07  
  
  
### Market Cap: $XXXXXXXXXXX [#](/topic/$arvn/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$arvn/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$arvn/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXX +$3%  
**1 Month**: $XXXXXXXXXXX +$23%  
**6 Months**: $XXXXXXXXXXX +$9.40%  
**1 Year**: $XXXXXXXXXXX -$62%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-11-11  
**1-Year Low**: $XXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Arvinas, Inc in the last XX hours

[Pfizer, Inc. (PFE)](/topic/$pfe)
[Dave Inc. Class A Common Stock (DAVE)](/topic/$dave)
[Moonft (MTC)](/topic/$mtc)
[CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr)
[Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan)
[Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls)
[Eli Lilly and Company (LLY)](/topic/$lly)

**Top topics mentioned**
In the posts about Arvinas, Inc in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [coins made in usa](/topic/coins-made-in-usa), [$pfe](/topic/$pfe), [$gsun](/topic/$gsun), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [discord](/topic/discord), [$dave](/topic/$dave), [stocks technology](/topic/stocks-technology), [$mtc](/topic/$mtc), [coins defi](/topic/coins-defi), [investment](/topic/investment), [$cmnd](/topic/$cmnd), [$crsp](/topic/$crsp), [eli lilly](/topic/eli-lilly), [stocks](/topic/stocks), [stocks financial services](/topic/stocks-financial-services), [breast cancer](/topic/breast-cancer), [$kymr](/topic/$kymr), [$elan](/topic/$elan), [stocks industrials](/topic/stocks-industrials), [$apls](/topic/$apls), [$lly](/topic/$lly), [$imab](/topic/$imab), [$tlsa](/topic/$tlsa), [$amph](/topic/$amph), [$absi](/topic/$absi), [coins base ecosystem](/topic/coins-base-ecosystem), [$spy](/topic/$spy), [momentum](/topic/momentum), [$snes](/topic/$snes), [$txmd](/topic/$txmd), [$rhhby](/topic/$rhhby), [money](/topic/money), [coins bsc](/topic/coins-bsc), [coins layer 1](/topic/coins-layer-1), [$bce](/topic/$bce), [$logi](/topic/$logi), [$mgy](/topic/$mgy), [$axta](/topic/$axta), [$cx](/topic/$cx), [coins dao](/topic/coins-dao), [$apld](/topic/$apld), [$uamy](/topic/$uamy), [$pepg](/topic/$pepg), [$uuu](/topic/$uuu), [coins](/topic/coins), [$spwh](/topic/$spwh), [$rhhy](/topic/$rhhy), [$kmda](/topic/$kmda), [$ptn](/topic/$ptn), [$abnb](/topic/$abnb), [$apps](/topic/$apps), [$elog](/topic/$elog), [amphenol](/topic/amphenol), [$nvda](/topic/$nvda), [$run](/topic/$run), [thomson reuters](/topic/thomson-reuters), [$100m](/topic/$100m), [100m](/topic/100m), [hims hers](/topic/hims-hers), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$hims](/topic/$hims), [lucid group inc](/topic/lucid-group-inc), [insider](/topic/insider), [$admq](/topic/$admq), [$lrcx](/topic/$lrcx), [$pali](/topic/$pali), [$120m](/topic/$120m), [primary market](/topic/primary-market), [$acog](/topic/$acog), [rocket companies inc](/topic/rocket-companies-inc), [$asts](/topic/$asts), [$rkt](/topic/$rkt), [$stocks](/topic/$stocks), [8k](/topic/8k), [has been](/topic/has-been), [united states](/topic/united-states), [rating agency](/topic/rating-agency), [$atge](/topic/$atge), [$asm](/topic/$asm), [coins nft](/topic/coins-nft), [$700m](/topic/$700m), [cuts](/topic/cuts), [$crml](/topic/$crml), [$ibkr](/topic/$ibkr), [$ciit](/topic/$ciit), [frost](/topic/frost), [$7b](/topic/$7b), [market cap](/topic/market-cap), [$12m](/topic/$12m), [$441k](/topic/$441k), [$423k](/topic/$423k), [$425k](/topic/$425k), [poa](/topic/poa), [up the](/topic/up-the), [os](/topic/os), [$celc](/topic/$celc), [$olma](/topic/$olma), [$35m](/topic/$35m), [drops](/topic/drops)

### Top Social Posts [#](/topic/$arvn/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@seedy19tron @Andre_AGTC @WallStSai don't short $celc brian sullivan. ;) roche data is bs - mutESR1 population is likely driving the benefit in the itt group. after $arvn data i don't see any serd winning in itt including $olma unless they fudge data by more favorable pt population"  
[X Link](https://x.com/financebully/status/1979577507788841389) [@financebully](/creator/x/financebully) 2025-10-18T15:57Z XXX followers, XXX engagements


"Roche pill delays tumor progression in closely watched breast cancer study @ByJonGardner $RHHBY $LLY $ARVN #ESMO25"  
[X Link](https://x.com/BentheFidler/status/1979537545487958161) [@BentheFidler](/creator/x/BentheFidler) 2025-10-18T13:18Z 8329 followers, XXX engagements


"@ByMadeleineA I assume theyll want contribution of components Seems short sighted that $pfe gave up given the others are clearly fudging their numbers with more favorable patient population. $arvn"  
[X Link](https://x.com/financebully/status/1979478632423645187) [@financebully](/creator/x/financebully) 2025-10-18T09:24Z XXX followers, XXX engagements


"Well these are the most promising signs I think we've seen in non-ESR1m pts with a SERD. And $RHHBY has been clever by enrolling XX% of pts in Evera with ESR1m. Now over to the FDA #ESMO25 $LLY $PFE $ARVN"  
[X Link](https://x.com/ByMadeleineA/status/1979466325064880363) [@ByMadeleineA](/creator/x/ByMadeleineA) 2025-10-18T08:35Z 8066 followers, 1459 engagements